Navigation Links
Latin American Peripheral Vascular Device Market Will Expand Strongly To reach Revenues of $335 Million in 2022
Date:11/12/2013

TORONTO, Nov. 12, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Latin American peripheral vascular (PV) device market will grow strongly through 2022. The rapidly expanding economies in the Latin American countries, mirrored by investment in health care, and coupled with increasing disease prevalence, are boosting both the accessibility of health care as well as the patient pool in the region. These factors will spur market growth at about eight percent annually through 2022.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO)

The drug-coated balloon (DCB) market represents an area of fast growth within the PV space. These products have gained popularity because they offer advantages over stenting or PV bypass, particularly in the lower extremities. They are also seen as a cost-saving measure; DCBs are less likely to require bail-out stenting of the vessel compared to standard balloons, and this results in overall lower procedure costs for facilities. DCB uptake will be particularly favorable in Argentina, where physicians are keen adopters of new technology, and in Colombia, where the lower cost of these products relative to other countries will spur faster acceptance. Penetration of these products will be slower in Brazil, where their cost is much closer to a stent and significantly higher than a standard balloon. In Mexico, DCB use will be hindered by the fact that many procedures are paid for out-of-pocket, and in those cases, patients will tend to opt for the lowest-cost procedures.

"The Latin American PV device market will be limited by strong competition from low-cost local manufacturers," said MRG Analyst Roald Dhoska. "The presence of value players will be particularly notable in the synthetic surgical graft and aortic stent graft markets in Brazil. While multinational companies will continue to dominate the private sector, low-cost domestic manufacturers such as Industrias Barone, Braile Biomedica and NANO have had considerable success in the public sector."

Millennium Research Group's Latin American Markets for Peripheral Vascular Devices 2014 report includes unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for PV stents, percutaneous transluminal angioplasty (PTA) balloon catheters, embolic protection devices, inferior vena cava filters (IVCFs), aortic stent grafts, synthetic surgical grafts and PV accessory devices in Argentina, Brazil, Colombia and Mexico. Supplemental country coverage is also available for Chile, Peru and Venezuela, as well as in aggregate for the rest of the Latin American countries.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
2. Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
3. Stage at Breast Cancer Diagnosis Will Shift Dramatically Over the Next 20 Years in Key Latin American Markets
4. Merrimack Pharmaceuticals Announces Results From A Phase 2 Study Of MM-121 (SAR256212) In Combination With Paclitaxel In Patients With Platinum-Resistant Or Refractory Advanced Ovarian Cancers
5. Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
6. University of Miami Program To Train Health Care Executives on Tackling Ethical and Compliance Issues When Doing Business in Latin America
7. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
8. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
9. ViSalus, Inc. Sets Sights on Aggressive Growth in Latino Market
10. Aethlon Medical to Present at Exosomes and Circulating Biomarkers 2013 Summit
11. North American and Latin American Economic Outlook: Gaining Traction or Losing Ground?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
Breaking Medicine Technology:
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):